| MAP | malignant atrophic papulosis; mandibular angle plane; maturation-activated protein; maximal aerobic ... |
|---|---|
| MTLP | metabolic toxemia of late pregnancy |
| NOAPP | National Organization of Adolescent Pregnancy and Parenting |
| OAP | Office of Adolescent Pregnancy; old age pension, old age pensioner; ophthalmic artery pressure; oste... |
| OAPP | Office of Adolescent Pregnancy Programs |
| cornual pregnancy | The implantation and development of the impregnated ovum in one of the cornua of the uterus. (05 Mar 2000) |
|---|---|
| pregnancy | The condition of having a developing embryo or foetus in the body, after union of an ovum and spermatozoon. (12 Dec 1998) |
| pregnancy, abdominal | Ectopic pregnancy with development of the foetus in the abdominal cavity. (12 Dec 1998) |
| pregnancy, alcohol in | The consumption of alcohol during pregnancy carries the danger of damaging the foetus and causing foetal alcohol syndrome or foetal alcohol effects. (12 Dec 1998) |
| pregnancy-associated alpha-plasma protein | An alpha 2-macroglobulin, molecular weight approximately 750,000 now believed to be a pregnancy-specific protein. Its plasma levels increase steadily during the second trimester and continue to rise until the end of gestation. (12 Dec 1998) |
| pregnancy-associated beta-plasma protein | A beta-globulin now believed to be a pregnancy-specific protein. Its plasma levels increase steadily during pregnancy until the end of gestation. (12 Dec 1998) |
| pregnancy-associated esterase | <enzyme> In baboons, amount of activity correlates with stage of pregnancy; hydrolyzes alpha-naphthyl butyrate in preference to alpha-naphthyl acetate Registry number: EC 3.1.1.- Synonym: pregnancy esterase (26 Jun 1999) |
| pregnancy cells | Hypophysial chromophobe cell's that increase in number and accumulate eosinophil granules during pregnancy. (05 Mar 2000) |
| pregnancy complications | The co-occurrence of pregnancy and a disease. The disease may precede or follow conception and it may or may not have a deleterious effect on the pregnant woman or foetus. (12 Dec 1998) |
| pregnancy complications, cardiovascular | The co-occurrence of pregnancy and a cardiovascular disease. The disease may precede or follow conception and it may or may not have a deleterious effect on the pregnant woman or foetus. (12 Dec 1998) |
| pregnancy complications, haematologic | The co-occurrence of pregnancy and a blood disease. The haematologic disorder may be of the cells or coagulation elements of the blood but does not refer to deficiencies or excesses of various substances in the blood, such as hypercalcaemia or hypocalcaemia. It may precede or follow conception and it may or may not have a deleterious effect on the pregnant woman or foetus. (12 Dec 1998) |
| pregnancy complications, infectious | Infections occurring during the course of pregnancy, or pregnancy during the course of an infectious disease. (12 Dec 1998) |
| pregnancy complications, neoplastic | Neoplasms occurring during the course of pregnancy, or pregnancy during the course of a neoplastic disease. (12 Dec 1998) |
| pregnancy complications, parasitic | Parasitic diseases occurring during the course of pregnancy, or pregnancy during the course of a parasitic disease. Some of the more commonly co-occurring infections are amebiasis, malaria and toxoplasmosis. (12 Dec 1998) |
| pregnancy danger from fifth disease | Caused by a virus known as parvovirus b 19. Symptoms include low-grade fever, fatigue, a slapped cheeks rash, and a rash over the whole body. The illness is not serious in children. Pregnant women (who have not previously had the illness) should avoid contact with patients who have fifth disease. The virus can infect the foetus prior to birth. And, while no birth defects have been reported as a result of fifth disease, it can cause the death of the unborn foetus. The risk of foetal death is 5-10% if the mother becomes infected. (12 Dec 1998) |